Dubai Stem Cell Congress 2025 To Focus On Innovations In Regenerative Medicine And Patient Success Stories

The First Stem Cell and Genomics Laboratory (FSG), previously known as Hortman Stem Cell Laboratory, is hosting the third Dubai Stem Cell Congress with support from the Dubai Health Authority. The event will gather 300-500 participants, including medical doctors, technologists, oncologists, and specialists. Additionally, 25 international speakers from leading scientific communities in stem cell and regenerative medicine will be present.

Dr. Fatma Al Hashimi, Chairperson of the Dubai Stem Cell Congress and Director of FSG, emphasised the congress's role in uniting top scientists to share insights and promote innovation. She stated: "The third edition of the Dubai Stem Cell Congress 2025 brings together leading scientists and researchers in the fields of stem cells and regenerative medicine to exchange insights, promote innovation and clinical trials."

The theme "Bridging the Future" aims to connect hope with scientific advancements by inviting global experts to share their latest research. This year's congress will feature patient success stories, keynote speeches, workshops, panel discussions, and networking opportunities. These activities aim to inspire hope for a healthier future through cutting-edge research.

A joint session with the International Society for Cell and Gene Therapy (ISCT) will highlight stem cell and gene therapy's impact on healthcare's future. Dr. Al Hashimi noted that "Connecting Hope" remains a key platform alongside this year's theme "Bridging the Future," focusing on attracting new technologies by inviting global experts to Dubai.

Dr. Al Hashimi stressed the importance of awareness about FDA-approved diseases treatable with stem cell therapy. Conditions like blood cancer, thalassemia, Fanconi anemia, and autoimmune diseases are treatable using these therapies. Other conditions such as autism, diabetes, and heart diseases are under clinical trials but not yet approved.

The congress aims to educate communities about recent research technologies and approved therapies in stem cell fields. Dr. Al Hashimi explained that umbilical cord blood stem cells play a crucial role in treating 80 FDA-approved blood diseases like thalassemia and leukemia.

Workshops and Networking Sessions

The event will cover recent topics in stem cell research through four workshops and two main networking sessions focused on developments in stem cells and gene therapy. Dr. Al Hashimi highlighted that these sessions aim to enhance understanding of scientific findings in this field.

The congress will also showcase top medical research posters prepared by students, with 20 submissions this year. The best poster will be announced and awarded during the event.

This gathering serves as a platform for sharing knowledge about innovative treatments while fostering collaboration among scientists worldwide.

With inputs from WAM